WebIf you're new to stock investing, here's how to buy Onconova Therapeutics stock. What is ONTX's forecast return on assets (ROA) for 2024-2024? (NASDAQ: ONTX) forecast ROA is -58.05%, which is lower than the forecast US Biotechnology industry average of 2.21%. Web12 de ago. de 2024 · Onconova Therapeutics, Inc. (ONTX) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.60 per share a year ago.
Onconova Therapeutics, Inc. Common Stock (ONTX) - Nasdaq
WebONTX has a Quality Grade of D, ranking ahead of 8.68% of graded US stocks. ONTX's asset turnover comes in at 0.007 -- ranking 403rd of 682 Pharmaceutical Products stocks. IDRA, MYMD, and CAPR are the stocks whose asset turnover ratios are most correlated with ONTX. The table below shows ONTX's key quality metrics over time. WebGet the latest Onconova Therapeutics Inc (ONTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … pink embroidery thread
Onconova Therapeutics (ONTX) Price To Free Cash Flow - Zacks.com
Web31 de mar. de 2024 · Onconova Therapeutics, Inc. Common Stock (ONTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Skip to … Web18 de mai. de 2024 · The microcap pharmaceutical company, Onconova Therapeutics (ONTX) hasadded ~26.1%in the pre-market after Guggenheim analyst Etzer Darout initiated its coverage with a buy rating and... WebHá 1 dia · Find the latest Price To Free Cash Flow for Onconova Therapeutics (ONTX) Skip to main content. We use cookies to understand how ... That means you want to buy stocks with a Zacks Rank #1 or #2, ... pink emerald cut diamond ring